HOME >> BIOLOGY >> NEWS
Pinpointing the protein problem in Lou Gehrigs Disease

TROY, NY The cause of Lou Gehrigs Disease (ALS or amyotrophic lateral sclerosis) has remained elusive since it brought down one of baseballs greatest players 60 years ago.

According to Wilfredo Freddie Coln, ALS starts when good proteins go bad. Understanding just why they go bad is a necessary first step toward developing medicines that will help ALS patients live with a manageable disease instead of a death sentence.

The Rensselaer biochemists vital research has recently earned a $1 million, four-year grant from the National Institutes of Health.

The NIH grant will support Colons study of the hereditary version of the disease, called familial ALS or FALS. He is attempting to understand why mutants of the enzyme superoxide dismutase (SOD1) fail and misfunction in FALS.

On average, FALS strikes people who are around 47 years of age, says Colon. Most patients die within two to five years. But some patients, whose proteins exhibit a different kind of mutation, experience a very slow progression and can survive for as long as 18 years, says Coln.

The existence of SOD1 mutants associated with this milder form of FALS makes it an intriguing biophysical and biochemical marker. Unlocking the mystery of the pathogenic causes for FALS could also play an important role for better understanding other neurogenerative disorders, such as Parkinsons and Alzheimers.

SOD1 is an enzyme that normally breaks down free radicals, highly reactive molecules that quickly damage DNA and proteins, thereby, endangering cells. However, the genetic defect that results in SOD1 mutations does not cause FALS because the normal function has been affected. Instead, a new mysterious toxic function of SOD1 leads to the death of motor neurons.

Faulty SOD1 behavior, caused by a number of different genetic mutations, is at the root of roughly one-fifth of inherited or familial ALS (FALS) cases. Around 10 percent of ALS cases are familial (FAL
'"/>

Contact: Megan Galbraith
galbrm@rpi.edu
518-276-6050
Rensselaer Polytechnic Institute
22-Mar-2002


Page: 1 2

Related biology news :

1. Pinpointing viruses in body scans
2. Pinpointing the mutations that cause resistance to Gleevec
3. Columbia Researchers Synthesize Compound With Possible Link To MacularDegeneration; Work Is Critical To Pinpointing Causes Of Disease, Scientists Say
4. New molecular link key to cellular proteins involved in cancer progression, other diseases
5. Researchers identify protein promoting vascular tumor growth
6. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
7. Experimental drug shown to block mutant protein causing blood disease
8. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
9. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
10. New dye directly reveals activated proteins in living cells
11. Disruption of protein-folding causes neurodegeneration, mental retardation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... 03, 2020 , ... Litmus Health , the research-ready ... of the company’s security practices has been completed. The assessment deemed Litmus infrastructure ... evaluation reviewed Litmus’ processes and systems, assessing them to see whether they adhere ...
(Date:8/26/2020)... ... August 25, 2020 , ... Modality Solutions, ... magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking of ... as well, and for this year’s list, reported three-year revenue growth of 71 percent. ...
(Date:8/21/2020)... ... August 19, 2020 , ... The 19th ... life science, data science, informatics and IT leaders goes VIRTUAL and announces its ... uncertainty and change, Bio-IT takes the leadership role of keeping our life science ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... , ... August 11, 2020 ... ... biopharmaceutical cold chain validation engineering firm, is making available for free its ... need to incorporate concurrent transport simulation testing into today’s biologics licensing application ...
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... President and CEO has been named one of the 100 most inspiring individuals ... PharmaVoice 100 honorees are selected based on how they have inspired their colleagues ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, ... its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes at ... requiring fast track capacity to provide patients with urgently needed vaccines and other ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
Breaking Biology Technology:
Cached News: